India, Oct. 3 -- The article outlines the slowdown in the company's US business and how it will counter it, as it continues to manufacture, develop, and market a wide range of branded and generic formulations and Active Pharmaceutical Ingredients.

With a market capitalization of Rs 4,34,280 crore, Sun Pharmaceutical Industries Ltd's share closed at Rs 1,810 per share, down by 0.56 percent from its previous close. The stock of the company gave a return of 10.32 percent over the last year.

Sun Pharmaceutical Industries Limited is India's largest pharmaceutical company and a major global specialty generic drug manufacturer. Founded in 1983 by Dilip Shanghvi, the company is headquartered in Mumbai and operates across more than 100 countrie...